Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston
boston blog main
boston top stories
funding
life sciences
national blog main
startups
20/20 healthcare partners
ally bridge group
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
bessemer venture partners
big data analytics
blackrock
casdin capital
christian angermayer
clinical trials
diabetes
diabetes type 2
diabetic nephropathy
dolby family ventures
enclear therapies
eventide asset management
financing
focal segmental glomerulosclerosis
fractyl labs
fundings & exits
general catalyst
gf securities
global health sciences fund
goldfinch bio
google ventures
gv
health
hillel bachrach
ido fund
irving investors
jason camm
What
develop
3
×
raised
3
×
diseases
million
new
raises
analysis
associated
associates
based
bessemer
bio
biotech
bring
capital
catalyst
companies
company
deerfield
developing
device
diabetes
dialysis
disease
domain
drug
drugs
emergent
employing
enclear
financing
firms
fractyl
fund
general
genetic
goldfinch
gv
harmful
ido
Language
unset
Current search:
develop
×
raised
×
biotech
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@techcrunch.com
6 years ago
Fractyl Labs raises $44 million in Series D to develop a treatment for type 2 diabetes
